Government of Canada invests in 14 new clinical trials to support Canada’s response to major health threats and bolster the life sciences sector
News release
August 13, 2024 – Ottawa, Ontario – Canadian Institutes of Health Research
The Government of Canada is committed to advancing the development of new treatments and tools with the potential to save lives, improve health outcomes, and strengthen Canada’s capacity for future innovation. To make sure health products in Canada are safe and effective, they must first be evaluated through clinical trials.
That is why today, the Honourable Mark Holland, Minister of Health, announced that the Government of Canada is investing more than $43 million to support 14 new clinical trials focused on preparing Canada to respond to future health emergencies and advancing the country’s life sciences sector.
The 14 clinical trials will assess treatments, diagnostic tests, and prevention tools for a wide range of health concerns including the flu, sepsis, stroke, tuberculosis, antimicrobial resistance, hepatitis C, COVID-19, and pneumonia.
These trials are being supported by the Canadian Institutes of Health Research (CIHR) Clinical Trials Fund, an important part of Canada’s Biomanufacturing and Life Sciences Strategy, and Canada’s Strategy for Patient-Oriented Research.
The full list of clinical trials can be found here: CIHR Clinical Trials Projects
Quotes
“Canada is home to many world-class researchers passionate about improving the health and wellness of Canadians and the world. Congratulations to the 14 clinical trials research teams whose projects are advancing the development of life-saving treatments.”
The Honourable Mark Holland
Minister of Health
“CIHR is proud to support 14 innovative clinical trials testing ground-breaking treatments and tools to protect people living in Canada from significant threats to our health. I am eager to see where these trials will lead.”
Dr. Tammy Clifford
Acting President, the Canadian Institutes of Health Research
Quick facts
-
Including this new investment, since 2022, more than $103.1M has been provided for 36 clinical trials projects through the CIHR Clinical Trials Fund, Canada’s Strategy for Patient-Oriented Research, and Canada's Centre for Research on Pandemic Preparedness and Health Emergencies, housed at CIHR.
-
The Clinical Trials Fund is an integral component of Canada’s Biomanufacturing and Life Sciences Strategy, which aims to strengthen research capacity in Canada and accelerate the development of new scientifically proven treatments and vaccines, to improve health outcomes for Canadians.
-
The Biomanufacturing and Life Sciences Strategy presents a long‑term vision to protect Canadians against future pandemics and other health emergencies and to grow an innovative, competitive domestic life sciences sector.
Related products
Associated links
Contacts
Matthew Kronberg
Press Secretary
Office of the Honourable Mark Holland
Minister of Health
343-552-5654
matthew.kronberg@hc-sc.gc.ca
Media Relations
Canadian Institutes of Health Research
mediarelations@cihr-irsc.gc.ca
At the Canadian Institutes of Health Research (CIHR) we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
Page details
- Date modified: